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Changhui Lu,a Yang Gu,a Jiang Wu,a Yucheng Gub and Qilong Shen *a
A palladium-catalyzed difluoromethylation of a series of heteroaryl chlorides, bromides and iodides under
mild conditions is described. A wide range of heteroaryl halides such as pyridyl, pyrimidyl, pyrazyl, funanyl,
thienyl, pyazolyl, imidazolyl, thiazolyl, and oxazolyl halides were efficiently difluoromethylated, thus
providing medicinal chemists an alternative choice for the preparation of drug candidates with the
difluoromethylated heteroarene unit.Introduction
Owing to the increased acidity of the proton in the diuor-
omethyl group that may interact with the targeting enzyme
through hydrogen bonding, the diuoromethyl group (–CF2H),
an analog of the well-recognized triuoromethyl group (–CF3) in
drug design,1 is generally considered by medicinal chemists as
a bioisostere of a hydroxyl or a thiol group that will enhance the
molecule's binding selectivity.2 On the other hand, in general,
the heteroaryl moiety is regarded as one of the most common
fragments in the majority of marketed drugs.3 As a logical
consequence, diuoromethylated heteroarenes that combine
benecial properties from both units could be conceived as
a promising family of pharmacores that are able to modulate
the lipophilicity, polarity, and hydrogen bonding capacity of
target molecules, and consequently the physiochemical and
pharmacokinetics of drugs. One of several examples that
support this point of view is the fact that 3-diuoromethylpyr-
azole4 is found to be the common core structural unit in four
recently marketed fungicides including bixafen, sedaxane, iso-
pyrazam and uxapyroxad (Fig. 1). Thus, methods that can
provide easy access to various diuoromethylated heteroarenes
under mild conditions may aid medicinal chemists in their
endeavor to hunt for novel lead compounds for new drug
discoveries.5
In the past several decades, three different strategies have
been reported for the preparation of diuoromethylated heter-
oarenes. The rst general method to obtain diuoromethylated
heteroarenes involved the use of uorinated precursors and
subsequent cyclocondensation of these building blocks withistry, Shanghai Institute of Organic
f Sciences, Chinese Academy of Sciences,
. E-mail: shenql@sioc.ac.cn
ch Centre Bracknell, Berkshire RG42 6EY,
tion (ESI) available. See DOI:other coupling partners to give a specic diuoromethylated
heteroarene and its derivatives. For example, Leroux success-
fully synthesized a series of diuoromethylated pyrazoles in
excellent yields by 1,3-dipolar cyclo-addition of the easily
available 1,1,2,2-tetrauoro-N,N-dimethylethan-1-amine
(TFEDMA) with hydrazine.6 This strategy is highly efficient for
the preparation of one type of diuormethylated heteroarenes.
Yet, the availability of the versatile diuoromethylated hetero-
arenes is limited. Alternatively, diuoromethylated hetero-
arenes may be accessed by direct radical diuoromethylation of
heteroarenes with a radical diuoromethylating reagent. For
example, in 2012, Baran5 reported that Zn(SO2CF2H)2 (DFMS)
can diuoromethylate a variety of nitrogen-containing hetero-
arenes such as pyridines, pyrroles, pyrimidines, quinoxalines,
pyrazines, xanthines, purines, quinoline, thiadiazoles, and
pyridinones.7 These reactions were proposed to proceed via
a radical pathway. Yet, regioselectivity in this method is prob-
lematic, which may cause difficulties in separation of the
resulting isomers. A third strategy for the preparation of
diuoromethylated heteroarenes relies on the transition metal-Fig. 1 Fungicides with 3-difluoromethylpyrazole core structural unit.
This journal is © The Royal Society of Chemistry 2017
Scheme 1 Optimization conditions for palladium-catalyzed difluor-
omethylation of 3-((benzyloxy)methyl)-5-bromopyridine. aReaction
condition: 3a (27.7 mg, 0.1 mmol), (SIPr)Ag(CF2H) 2 (55 mg, 0.1 mmol),
[Pd] (5 mol%) and ligand (10 mol%) in 1.0 mL toluene for 6 h under Ar
atmosphere; byields were determined by 19F NMR analysis of the crude
reaction mixture with trifluorotoluene as an internal standard; c1.3
equiv. of (SIPr)Ag(CF2H) was used;
d[Pd] (2.0 mol%) and DPEPhos (4.0
mol%).
Fig. 2 Stoichiometric reaction of complex [(xantphos)Pd(3-Py)(Br)] 1
with [(SIPr)Ag(CF2H)] 2 at room temperature.
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View Article Onlinemediated or -catalyzed diuoromethylation of heteroaryl elec-
trophiles, such as heteroaryl diazonium salts or halides, with an
appropriate nucleophilic diuoromethylating reagent.8 While
several transitionmetal-mediated/-catalyzed diuoromethylation
of aryl halides have been reported to occur with broad scope,
efforts for a similar transformation with heteroaryl electrophiles
achieved only limited success. For example, Prakash and
coworkers reported that copper-mediated diuoromethylation of
2-iodo-pyridine or 2-iodo-quinoline with Bu3SnCF2H was ob-
tained in moderate to good yields, while similar transformation
of more challenging heteroaryl halides such as 3-iodopyridine or
halothiophenes were not described.8c More recently, Vicic and
coworkers reported the preparation of a new diuoromethylating
reagent (DMPU)Zn(CF2H)2 that was allowed to couple with iodo-
or bromo-substituted pyridine, quinoline, furan or thiophene in
good yields in the presence of a nickel catalyst.8h However, a high
catalyst loading of nickel complex (15 mol%) was required and
the turnover number of the catalytic reaction was not high
enough. Shortly aer, Mikami reported that (DMPU)Zn(CF2H)2
was able to couple with several activated heteroaryl iodides in the
presence of 10 mol% of CuI, while reactions of non-activated
heteroaryl iodides or heteroaryl bromides occurred with much
less efficiency.8f Later on, Mikami and coworkers developed
(TMEDA)Zn(CF2H)2 that was allowed to couple with two activated
heteroaryl iodides in high yields.8g Clearly, new methods that
allow the generation of a variety of diuoromethylated hetero-
arenes under mild conditions are still urgently needed.
Very recently, we developed a cooperative bimetallic Pd/Ag
catalyst system that was quite efficient for the catalytic
diuoromethylation of various aryl bromides and iodides with
TMSCF2H.9 Nevertheless, our efforts to extend this catalyst
system for the diuoromethylation of heteroaryl halides only
resulted in moderate yields. We realized that to successfully
develop efficient methods for the diuoromethylation of het-
eroaryl halides, we need to overcome two challenges: (1)
reductive-elimination from a key product-forming intermediate
[L2Pd(heteroaryl)(CF2H)] is much slower than that from [L2-
Pd(aryl)(CF2H)]; (2) the heteroatommay competingly coordinate
to the palladium catalyst and consequently, the phosphino
ligand in the catalyst may be replaced by the heteroarene
substrates, which may lead to the deactivation of the catalyst.
In this report, we detailed the development of an effecient
palladium-catalyst that overcomes these challenges and is
capable of direct diuoromethylation of a vast range of different
bromo- or iodo-substituted heteroarenes such as pyridine,
pyrimidine, pyrole, funan, thiophene, quinoline, carbazole,
dibenzo[b,d]thiophene, pyrazine, thiazole, oxazole, pyrazole and
activated heteroaryl chlorides. Furthermore, the current method
was successfully applied to the synthesis of three examples of
diuoromethylated natural product derivatives.
Results and discussion
In order to overcome the challenges associated with the
palladium-catalyzed diuoromethylation of the heteroarene
halides, we began our investigation by preparing the key inter-
mediates and studying their elementary steps in the catalytic cycle.This journal is © The Royal Society of Chemistry 2017Our choice of xantphos as the ligand for the putative palladium
intermediates was guided by previous observations in stoichio-
metric or catalytic organometallic chemistry: (1) reductive elimi-
nation is accelerated by wide bite angle bisphosphine ligands in
various transition-metal-catalyzed C–C bond formation reac-
tions.10 For example, Grushin reported that reductive-elimination
from xantphos-ligated triuoromethylated palladium complex
[(xantphos)Pd(Ph)(CF3)] was much faster than those ligated with
other bidendate ligands;11 (2) xantphos-ligated palladium complex
[(xantphos)Pd(heteroaryl)(X)] (X¼ halide or amine) is able to resist
the ligand replacement by the heteroaryl substrates. For example,
Yin and coworkers have reported that palladium complex ligated
with xantphos was able to efficiently catalyze the amination reac-
tions of a broad range of heteroaryl halides even at high temper-
atures.12 Accordingly, [(xantphos)Pd(3-Py)(Br)] was prepared by
following a known procedure.11 Interestingly, mixing a 1/1 ratio of
[(xantphos)Pd(3-Py)(Br)] and [(SIPr)Ag(CF2H)] (SIPr ¼ 1,3-bis(2,6-
diisopropyl phenyl)imidazolin-2-ylidene), a nucleophilic diuor-
omethylating reagent which was isolated in our laboratory previ-
ously, generated the reductive-elimination product 3-Chem. Sci., 2017, 8, 4848–4852 | 4849
Scheme 2 Scope of the palladium-catalyzed difluoromethylation of
heteroaryl bromides. aReaction conditions: heteroaryl bromide (0.5
mmol), (SIPr)Ag(CF2H) 2 (0.65 mmol), Pd(dba)2 (5.0 mol%), DPEPhos
(10 mol%) in 2.0 mL toluene at 80 C for 6–12 h under an argon
atmosphere; bisolated yields; cPd(dba)2 (10 mol%) and DPEPhos (20
mol%) are used; dreactions conducted with Pd(dba)2 (10 mol%) and
DPEPhos (20 mol%) for 24 h.
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View Article Onlinediuoromethylpyridine in 50% yield aer 1 h at room tempera-
ture, as determined by 19F NMR spectroscopy Fig. 2. These results
clearly suggest that C–CF2H bond-forming reductive elimination
from [(xantphos)Pd(3-Py)(CF2H)] is a facile process even at room
temperature and likely not the rate-limiting step of the catalytic
reaction.
Having established that reductive elimination from xantphos-
ligated complex [(Xantphos)Pd(3-Py)(CF2H)] proceeds smoothly
even at room temperature, we explored the cooperative bimetallic
Pd/Ag catalyst system using xantphos as the ligand for the reac-
tion of 3-((benzyloxy)methyl)-5-bromopyridine with TMSCF2H
with NaOtBu as the base. However, low yield was observed, likely
due to the incompatibility of the elementary reactions in two
catalytic cycles. Instead, when [(SIPr)Ag(CF2H)] was used as the
nucleophilic diuoromethylation reagent, the formation of the
desired product was observed in 60% yield aer 6 h at 80 Cwhen
a combination of 5.0 mol% Pd(dba)2 and 10.0 mol% xantphos
was used as the catalyst (Scheme 1, entry 1). The yield was
improved to 80% when another bidentate bisphosphino ligand
with a wide bite angle DPEPhos was used as the ligand (Scheme
1, entry 2). In contrast, catalysts generated from ligands with
smaller bite angle ligand such as DPPF, BINAP, DPPE were less
effective, forming the desired product in 65%, 17% and less than
2% yields, respectively (Scheme 1, entries 3–5). Likewise, catalyst
derived from sterically hindered, electron-rich, mono-dentate
phosphine brettphos was also less effective (Scheme 1, entry 6).
Next, we studied the effect of the different palladium precursors
on the palladium-catalyzed diuoromethylation of the heteroaryl
bromide. It turned out that reactions occurred in lower yields
when catalysts derived from Pd(PPh3)4, Pd(OAc)2, PdCl2 or
[Pd(cinnamyl)(Cl)]2 were used (Scheme 1, entries 7–10). Finally,
the yield of the desired product was further improved to 90%
when 1.3 equivalents of [(SIPr)Ag(CF2H)] was used (Scheme 1,
entry 11), while efforts to decrease the catalyst loading were
ineffective. Lower yield (50%) was observed when 2.0 mol%
Pd(dba)2/4.0 mol% DPEPhos was used as the catalyst (Scheme 1,
entry 12).
With the above optimized reaction conditions, we rst
studied the diuoromethylation of an array of heteroaryl
bromides to investigate the generality and scope of the reaction.
As summarized in Scheme 2, a wide range of electron-decient
bromo-substituted nitrogen containing heteroarenes such as
pyridine (3a–k), pyrimidine (3l–o), pyrazine (3p–q), quinoline (3r–
t), isoquinoline (3u–w), 1H-pyrrolo[2,3-b]pyridine (3x), quinoxa-
line (3y), imidazo[1,2-a]pyrazine (3z), pyrido[2,3-b]pyrazine (3aa)
underwent diuoromethylation smoothly under mild conditions
to produce the corresponding diuoromethylated heteroarenes
4a–4aa in high yields. Remarkably, these reaction conditions can
also be applied to electron-rich bromo-substituted heteroarenes
that are typically more challenging substrates due to slow
oxidative addition/reductive-elimination, although reactions of
these bromo-heteroarenes are slower (24 h) and require higher
catalyst loading (10 mol% Pd(dba)2 and 20 mol% DPEPhos) to
proceed to full conversion. Nevertheless, good to excellent yields
for the formation of a variety of diuoromethylated electron-rich
heteroarenes including thiophene (4ab–ad), benzothiophene
(4ae–4af, 4ak), furan (4ag), dibenzo[b,d]furan (4ah), benzofuran4850 | Chem. Sci., 2017, 8, 4848–4852(4ai–aj), indole (4an), benzo[d]oxazole (4al), benzo[d]thiazole
(4am), indazole (4ao) and carbazole (4ap) were achieved. Notably,
bromo-substituted heteroarenes with functional groups such
esters, cyano, protected aldehyde, enolizable ketone, thioether,
or Boc-protected amino group, all underwent smooth diuor-
omethylation, illustrating the good functional compatibility of
the current method. Furthermore, the reaction is scalable. The
reaction of 1.0 g of 1-(5-bromothiophen-2-yl)ethanone withThis journal is © The Royal Society of Chemistry 2017
Scheme 3 Scope of the palladium-catalyzed difluoromethylation of
heteroaryl chlorides. aReaction conditions: heteroaryl chlorides (0.5
mmol), (SIPr)Ag(CF2H) 2 (0.65 mmol), Pd(dba)2 (5 mol%), DPEPhos (10
mol%) in toluene (2.5 mL) at 80 C for 18 h; bisolated yields. Fig. 3 Preparation of difluoromethylated derivatives of drug
compounds.
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View Article Online[(SIPr)Ag(CF2H)] 2 formed 0.50 g of the corresponding product
4ab in 57% yield under the standard conditions (Scheme 2, 4ab).
In general, carbon–iodine bonds in heteroarenes are weaker
than carbon–bromide bonds and the Pd-catalyzed cross-
coupling reactions are easier. In fact, reactions of a few heter-
oaryl iodides with [(SIPr)Ag(CF2H)] 2 in the presence of 5.0
mol% or Pd(dba)2/10.0 mol% of DPEPhos occurred smoothly
aer 18 h at 80 C to give the corresponding diuoromethylated
heteroarenes in good to excellent yields (Scheme 3, 5a–d). For
example, reaction of 4-iodo-1-(4-methoxyphenyl)-1H-pyrazole
with [(SIPr)Ag(CF2H)] 2 generated the corresponding 4-diuor-
omethyl-1-(4-methoxyphenyl)-1H-pyrazole 5d in 60% yield,
while efforts to convert its analog 3-iodo-1-(4-methoxyphenyl)-
1H-pyrazole resulted in low yield (Scheme 3, 5d). On the other
hand, carbon–chloride bonds in heteroarenes are stronger than
carbon–bromide bonds and the Pd-catalyzed cross-coupling
reactions are much more difficult. Nevertheless, it was found
that activated heteroaryl chlorides, in which the chlorine atom
is at the ortho-position of the heteroatom in the heteroarene,
coupled with [(SIPr)Ag(CF2H)] 2 under optimized conditions to
give the corresponding diuoromethylated heteroarenes in
high yields (Scheme 3, 5e–p). When the carbon–chloride bond
was at the meta- or para-position of the heteroatom in the het-
eroarene, the formation of the diuoromethyled heteroarene
was not observed. For example, reaction of ethyl 4,6-dichlor-
onicotinate with [(SIPr)Ag(CF2H)] 2 generated exclusively ethyl
4-chloro-6-diuoromethylnicotinate in 75% yield (Scheme 3,
5h). The 4-diuoromethylated isomer was not observed. Control
experiments in the absence of the palladium catalyst did not
form the corresponding diuoromethylated product. To the
best of our knowledge, this represents the rstThis journal is © The Royal Society of Chemistry 2017diuoromethylation reaction of heteroaryl chloride by any
transition metal catalyst.
To demonstrate the applicability of this difuoromethylating
protocol, we applied this method to the difuoromethylation of
three medicinally important compounds. Compound 6a,
a difuoromethylthiolated analog of imiquimod,13 a medication
that acts as an immune response modier to treat genital warts,
was generated in a 93% yield. Likewise, compound 6b, a diuor-
omethylated derivative of herbicide safener cloquintocet-mexyl,14
was formed in 58% yield under standard reaction conditions.
Furthermore, a difuoromethylated derivative of vitamin E was
prepared from its bromo-substituted precursor in a 92% yield
under standard reaction conditions (Fig. 3).Conclusions
In summary, we have developed a palladium-catalyzed direct
diuoromethylation of heteroaryl chlorides, bromides, and
iodides. The reaction was conducted under mild reaction
conditions and several common functional groups were toler-
ated. Thus, the current method represents the rst general
method for the site-specic incorporation of diuoromethyl
into heteroarenes. Currently, expansion of the reaction scope to
aryl chlorides and unactivated heteroaryl chlorides are under-
going in our laboratory.Acknowledgements
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